0001354457-12-000123.txt : 20120615
0001354457-12-000123.hdr.sgml : 20120615
20120615092105
ACCESSION NUMBER: 0001354457-12-000123
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20120615
DATE AS OF CHANGE: 20120615
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21615
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0000830656
PRESSURE BIOSCIENCES INC
000-21615
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
508 230-1828
Common stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2012-06-14
EX-99.25
2
pbiodelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
June 14, 2012, Pressure BioSciences, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Pressure BioSciences, Inc.
(the Company), effective at the opening of the trading
session on June 25, 2012. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(1). The
Company was notified of the Staffs determination on
October 4, 2011. The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated December 7, 2011, modified
on March 7, 2012, granting the Company continued listing
pursuant to an exception that extended to April 9, 2012,
so long as certain conditions were met prior to that
date, and so long as the Company was fully
in compliance with Listing Rules
5550(b)(1) and 5550(a)(2) by that date.
However, the Company did not meet all of the
conditions as required by the Panel decision. On April 3, 2012,
the Panel issued a final delisting determination and
notified the Company that trading in the Companys
securities would be suspended on April 5, 2012.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on May 18, 2012.